Search results
Results from the WOW.Com Content Network
Isoprenaline was discovered in 1940 [5] and was developed in the 1940s. [7] It was first approved for medical use in 1947 in the United States. [15] Isoprenaline was one of the first synthetic sympathomimetic amines, was the first selective β-adrenergic receptor agonist, and was the first major sympathomimetic agent devoid of pressor effects ...
Prior to their discovery, the non-selective beta-agonist isoprenaline was used. The aim of the drug development through the years has been to minimise side effects, achieve selectivity and longer duration of action. The mechanism of action is well understood and has facilitated the development.
The mechanisms of sympathomimetic drugs can be direct-acting (direct interaction between drug and receptor), such as α-adrenergic agonists, β-adrenergic agonists, and dopaminergic agonists; or indirect-acting (interaction not between drug and receptor), such as MAOIs, COMT inhibitors, release stimulants, and reuptake inhibitors that increase the levels of endogenous catecholamines.
The mechanism of adrenoreceptors. Adrenaline or noradrenaline are receptor ligands to either α 1, α 2 or β-adrenoreceptors. The α 1 couples to G q, which results in increased intracellular Ca 2+ and subsequent smooth muscle contraction.
Vibegron is, in contrast to other OAB drugs, very selective and leads to a lesser degree of unwanted side effects. Vibegron is found to be a substrate for CYP3A4 in vivo, but does not actually induce or inhibit any of the cytochrome P450 enzymes and is thus less likely to take part in drug–drug interactions (DDI).
Dichloroisoprenaline (DCI), also known as dichloroisoproterenol, was the first beta blocker ever to be developed. It is non-selective for the β 1-adrenergic and β 2-adrenergic receptors.
Poppers (or popper) is a slang term referring to recreational drugs belonging to the alkyl nitrite family of chemical compounds.When fumes from these substances are inhaled, they act as potent vasodilators, producing mild euphoria, warmth, and dizziness.
The 2001 Nobel Prize in Chemistry was also related to l-DOPA: the Nobel Committee awarded one-quarter of the prize to William S. Knowles for his work on chirally catalysed hydrogenation reactions, the most noted example of which was used for the synthesis of l-DOPA. [14] [15] [16] Synthesis of l-DOPA via hydrogenation with C 2-symmetric ...